• IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator

    8 days ago - By Xconomy

    IFM Therapeutics has raised $55.5 million to launch its third drug subsidiary as well as an incubator, both of which are focused on developing new therapies for inflammatory diseases and cancers. Those endeavors will be led by a familiar face. Boston-based IFM has promoted its vice president of research and development, Martin Seidel, to become its CEO and a member of the board of directors. Gary Glick, IFM's co-founder and CEO since its formation two years ago , is taking on a new role as executive chairman of the board. IFM Therapeutics operates a business structure that houses its...
    Read more ...